Edwards Lifesciences
EW • NYSE
Edwards Lifesciences is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Bernard J. Zovighian, with a market cap of $45.7B.
CEOBernard J. Zovighian
Next Earnings
Upcoming earnings announcement for Edwards Lifesciences
Date
Wednesday, April 22, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.72
Revenue Estimate
$1.6B
Earnings History
Past 12 earnings reports for Edwards Lifesciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q4 2025 | $0.58Est: $0.62 | -6.5% | $1.6BEst: $1.5B | +1.8% |  10-K |
| Oct 30, 2025 | Q3 2025 | $0.67Est: $0.59 | +13.6% | $1.6BEst: $1.5B | +3.7% | 10-Q |
| Jul 24, 2025 | Q2 2025 | $0.67Est: $0.62 | +8.1% | $1.5BEst: $1.5B | +3.0% | 10-Q |
| Apr 23, 2025 | Q1 2025 | $0.64Est: $0.60 | +6.7% | $1.4BEst: $1.4B | +0.7% | 10-Q |
| Feb 11, 2025 | Q4 2024 | $0.59Est: $0.55 | +7.3% | $1.4BEst: $1.4B | +1.9% | 10-K |
| Oct 24, 2024 | Q3 2024 | $0.67Est: $0.64 | +4.7% | $1.4BEst: $1.5B | -10.9% | 10-Q |
| Jul 24, 2024 | Q2 2024 | $0.70Est: $0.69 | +1.4% | $1.6BEst: $1.7B | -1.1% | 10-Q |
| Apr 25, 2024 | Q1 2024 | $0.66Est: $0.64 | +3.1% | $1.6BEst: $1.6B | +1.8% | 10-Q |
| Feb 6, 2024 | Q4 2023 | $0.64Est: $0.64 | 0.0% | $1.5BEst: $1.5B | +3.0% | 10-K |
| Oct 25, 2023 | Q3 2023 | $0.59Est: $0.59 | 0.0% | $1.5BEst: $1.5B | +0.1% | 10-Q |
| Jul 26, 2023 | Q2 2023 | $0.66Est: $0.65 | +1.5% | $1.5BEst: $1.5B | +2.0% | — |
| Apr 26, 2023 | Q1 2023 | $0.62Est: $0.61 | +1.6% | $1.5BEst: $1.4B | +5.0% | — |